66th ASH Annual Meeting: 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Optimizing Classical Hematology Care

Symposia: Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies Oral and Poster Abstracts
Oral

Bleeding and Clotting, Bleeding disorders, Adult, Research, Artificial intelligence (AI), Clinical Practice (Health Services and Quality), Hemophilia, Translational Research, Epidemiology, Assays, Clinical Research, Health outcomes research, Thromboembolism, Education, Health disparities research, Diversity, Equity, and Inclusion (DEI), Pediatric, Diseases, Thrombocytopenias, Thrombotic disorders, Treatment Considerations, Non-Biological therapies, Technology and Procedures, Study Population, Human, Natural language processing

Room 31 (San Diego Convention Center)

Moderators:

Kelly Bush, MD, ARRAY(0xe47d8fc) and Camila Masias, MD, MPH,

Disclosures:

No relevant conflicts of interest to declare.

12:00 PM

157

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Samira Glaeser-Khan, BS¹^*, Rhys Richmond, BS¹^*, Satoko Ito, MD, PhD², Robert D Bona, MD², Harlan M. Krumholz, MD, SM³^*, Adam Cuker, MD MS⁴ and George Goshua, MD, MSc, FACP^3,5

¹Yale School of Medicine, New Haven, CT
²Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
³Center for Outcomes Research and Evaluation, Yale University and Yale New Haven Hospital, New Haven, CT
⁴Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁵Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

12:15 PM

158

Improving Guideline Concordant Primary Prevention Aspirin Use through a Multiclinic Antithrombotic Stewardship Intervention

Jordan K Schaefer, MD, MSc¹, Naina Chipalkatti, MD², Linda Bashaw²^*, Adam Davie, MD²^*, Joelle Ellis¹^*, Molly Harrod, PhD³^*, Jacob E Kurlander, MD, MS⁴^*, Christine Medaugh, MD⁵^*, Rebeca Packard, MS, RN⁶^*, Corey Powell, PhD⁷^*, Suman L Sood, MD, MSCE¹, Elizabeth Spranger²^*, Sarah Vordenberg, PharmD, MPH⁸^* and Geoffrey D Barnes, MD, MSc⁹^*

¹Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
²Department of Internal Medicine, University of Michigan, Ann Arbor, MI
³VA Ann Arbor Healthcare System, Ann Arbor, MI
⁴Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
⁵Department of Family Medicine, University of Michigan, Ann Arbor, MI
⁶Health Information Technology & Services, University of Michigan, Ann Arbor, MI
⁷Consulting for Statistics, Computing & Analytics Research, University of Michigan, Ann Arbor, MI
⁸Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI
⁹Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI

12:30 PM

159

The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

Joud El Dick, MD¹, Jackson Hoesley, MD²^*, Rance C. Siniard, MD³^*, Laura J. Taylor, MT⁴^*, Cari E. Reed, MT⁴^*, Marisa B. Marques, MD³^* and Jori E. May, MD¹

¹Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
²Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
³Department of Pathology, Division of Laboratory Medicine, University of Alabama At Birmingham, Birmingham, AL
⁴Special Coagulation Laboratory, University of Alabama at Birmingham, Birmingham, AL

12:45 PM

160

The Caprini Score in Black and Latino Patients: A Proposed Race- and Ethnicity-Adjusted Model for Perioperative Venous Thromboembolism Risk Assessment

Ahmad Nassar, MBBS¹, Ryan Sun, MD²^*, Danny Hadidi³^*, Margaret E Wright⁴^*, Subhash K Kolar Rajanna⁵^*, Sargam Kapoor, MBBS⁶, Thomas L. Ortel, MD, PhD⁷ and John G Quigley⁸

¹University of Illinois Chicago, Chicago, IL
²Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL, Chicago, IL
³Department of Internal Medicine, St. Luke's Hospital, Chesterfield, MO
⁴University of Illinois Cancer Center, Chicago, IL
⁵Center for Clinical and Translational Science, University of Illinois Chicago, Chicago
⁶Division of Hematology, Department of Medicine, Duke University, Durham, NC
⁷Division of Hematology, Duke University School of Medicine, Durham, NC
⁸Division of Hematology/Oncology, University of Illinois, Chicago, Chicago, IL

1:00 PM

161

Optimized Multi-Class VTE-BERT Large Language Model for Prediction of Cancer Associated Thrombosis Phenotype

Ang Li, MD, MS¹, Omid Jafari, PhD¹^*, Shengling Ma, MD, PhD², Arash Maghsoudi³^*, Barbara D Lam, MD⁴, Justine Ryu, MD⁵, Jun Yang Jiang, MD⁶^*, Mrinal Ranjan, MPH¹^*, Emily Zhou⁷^*, Raka Bandyo, MS⁸^*, Bo Peng⁹^*, Christopher I Amos¹^*, Nathanael R. Fillmore, PhD^10,11^*, Abiodun O. Oluyomi¹²^* and Jennifer La¹¹^*

¹Baylor College of Medicine, Houston, TX
²Section of Hematology-Oncology, Baylor College of Medicine, HOUSTON, TX
³Health Services Research Department of Medicine, Baylor College of Medicine, Houston, TX
⁴Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
⁵Section of Hematology, Yale University School of Medicine, New Haven, CT
⁶Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
⁷McGovern Medical School, University of Texas Health Science Center, Houston, TX
⁸Harris Health System, Houston, TX
⁹Baylor College of Medicine, houston, TX
¹⁰Harvard Medical School, Boston, MA
¹¹VA Boston Healthcare System, Boston, MA
¹²Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX

1:15 PM

162

Cost-Effectiveness of Universal Duffy Testing at 9-12 Months: An Effort Towards Equity in Interpreting Absolute Neutrophil Counts (ANC)

Lauren E. Merz, MD, MSc^1,2, Satoko Ito, MD, PhD³, Kelly J. Walkovich, MD^4,5, Maureen Okam Achebe, MD, MPH⁶, Nathalie van Havre, MD, MS, FRACP⁷, Patricia Frustace⁷ and George Goshua, MD, MSc, FACP⁸

¹Division of Hematology/Oncology, Mass General Brigham, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
³Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
⁴University of Michigan, Ann Arbor, MI
⁵C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI
⁶Brigham and Women's Hospital, Harvard Medical School, Boston, MA
⁷American Society of Hematology, Washington, DC
⁸Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

901.O2.6 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Optimizing Classical Hematology Care